Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium

BACKGROUND: Indacaterol is a novel, inhaled, once-daily, ultra-long-acting β(2)-agonist for the treatment of chronic obstructive pulmonary disease (COPD). This randomized, double-blind study compared the bronchodilator efficacy of indacaterol with that of placebo and tiotropium in patients with mode...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Vogelmeier, Claus, Ramos-Barbon, David, Jack, Damon, Piggott, Simon, Owen, Roger, Higgins, Mark, Kramer, Benjamin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2010
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2964613/
https://ncbi.nlm.nih.gov/pubmed/20920365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-11-135
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items